JW (Cayman) Therapeutics Co. Ltd
JW (Cayman) Therapeutics Co. Ltd is a Shanghai-based developer of cell-based therapy technologies for cancer treatment.
2
Funding Rounds
$195.5m
Money raised
Overview
JW (Cayman) Therapeutics Co. Ltd is a Shanghai-based developer of cell-based therapy technologies for cancer treatment.
- Website:
- Business model: B2B
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company JW (Cayman) Therapeutics Co. Ltd has raised a total of $90m in funding over 2 rounds.
Key Insights:
- JW (Cayman) Therapeutics Co. Ltd Series A round, March 2018: $90m
- JW (Cayman) Therapeutics Co. Ltd funding round, July 2020: $105.55m
JW (Cayman) Therapeutics Co. Ltd Series A round, March 2018
$90m
JW (Cayman) Therapeutics Co. Ltd funding round, July 2020
$105.55m
Industries
JW (Cayman) Therapeutics Co. Ltd is active in the following industries: